ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Valerio Therapeutics

Valerio Therapeutics (ALVIO)

0.065
-0.0011
(-1.66%)
Closed 27 April 1:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.065
Bid
0.064
Offer
0.0659
Volume
25,197
0.063 Day's Range 0.0659
0.0401 52 Week Range 0.1398
Market Cap
Previous Close
0.0661
Open
0.064
Last Trade
5000
@
0.065
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
336,523
Shares Outstanding
154,364,273
Dividend Yield
-
PE Ratio
-9.71
Earnings Per Share (EPS)
-0.13
Revenue
4.45M
Net Profit
-20.34M

About Valerio Therapeutics

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Paris, Paris, Fra
Founded
-
Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.07 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.0401 € to 0.1398 €.

Valerio Therapeutics currently has 154,364,273 shares in issue. The market capitalisation of Valerio Therapeutics is 10.20 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

ALVIO Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.003-4.411764705880.0680.0680.0621503020.06318602DE
4-0.0004-0.6116207951070.06540.07480.0521238610.06460905DE
12-0.012-15.58441558440.0770.10880.04013365230.06743375DE
26-0.0173-21.02065613610.08230.13980.04012296410.07243914DE
52-0.049-42.98245614040.1140.13980.04011559270.07981377DE
156-0.208-76.19047619050.2730.3480.04011215220.11648079DE
260-0.208-76.19047619050.2730.3480.04011215220.11648079DE

ALVIO - Frequently Asked Questions (FAQ)

What is the current Valerio Therapeutics share price?
The current share price of Valerio Therapeutics is 0.065 €
How many Valerio Therapeutics shares are in issue?
Valerio Therapeutics has 154,364,273 shares in issue
What is the market cap of Valerio Therapeutics?
The market capitalisation of Valerio Therapeutics is EUR 10.2M
What is the 1 year trading range for Valerio Therapeutics share price?
Valerio Therapeutics has traded in the range of 0.0401 € to 0.1398 € during the past year
What is the PE ratio of Valerio Therapeutics?
The price to earnings ratio of Valerio Therapeutics is -9.71
What is the cash to sales ratio of Valerio Therapeutics?
The cash to sales ratio of Valerio Therapeutics is 44.44
What is the reporting currency for Valerio Therapeutics?
Valerio Therapeutics reports financial results in EUR
What is the latest annual turnover for Valerio Therapeutics?
The latest annual turnover of Valerio Therapeutics is EUR 4.45M
What is the latest annual profit for Valerio Therapeutics?
The latest annual profit of Valerio Therapeutics is EUR -20.34M
What is the registered address of Valerio Therapeutics?
The registered address for Valerio Therapeutics is 49 BOULEVARD DU GENERAL MARTIAL VALIN, PARIS, PARIS, 75015
What is the Valerio Therapeutics website address?
The website address for Valerio Therapeutics is valeriotx.com/
Which industry sector does Valerio Therapeutics operate in?
Valerio Therapeutics operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALSENSensorion
0.2092 €
(34.53%)
2.23M
EBUSEbusco Holding NV
0.6485 €
(27.66%)
5.29M
MLFXOFinaxo
2.26 €
(19.58%)
808
MLSMLSmalto
0.015 €
(15.38%)
2k
ALLDLLDLC Groups
7.70 €
(14.93%)
24.07k
PHXMPHAXIAM Therapeutics SA
0.1515 €
(-73.88%)
234.8k
ALCHIAlchimie
0.231 €
(-42.25%)
365.3k
ALNEVNeovacs
0.013 €
(-23.08%)
3.18M
ALOKWGroupe Okwind SA
1.57 €
(-21.18%)
61.01k
MLNMAMiguet Et Associes
0.15 €
(-20.21%)
250
ALEUPEuroplasma
0.017 €
(11.11%)
326.62M
ALVERVergnet
0.0007 €
(0.00%)
294.39M
ALALOAcheterLouerFR
0.0004 €
(-20.00%)
270.92M
ALHPIHopium SA
0.0009 €
(-10.00%)
109.33M
BCPBanco Comercial Portugues SA
0.5684 €
(1.97%)
57.02M

Discussion

View Full Feed
VikingDiviner97 VikingDiviner97 48 seconds ago
$BTBT $BTDR $CGAC ok guys and gals, just going off the fin
BTBT BTDR CGAC
Nebuchadnezzar Nebuchadnezzar 4 minutes ago
$0.01+ potential? higher?
RITE
WolfofMia WolfofMia 4 minutes ago
35 years old EE, do some simple math.

And my head fits in every room I enter!

I have a great diet and I do avoid motorcycles and all of that try hard stuff.

Why do choose to missinform about institutional interest and short positioning?

Wh
AVXL
chen1992 chen1992 13 minutes ago
Realistically speaking, assuming they want to FID on the 1st vessel only, it wouldn’t make sense. They complained all they needed was the MARAD & DOE permits and now have the permits on hand, and have enough contracts to fill the 1st vessel, maybe even 2 or all 3, BUT….. its delfin, the boy who crie
TGLO
alertmeipp alertmeipp 13 minutes ago
I think it can go either way, no doubt that waiting for HR data can potentially bring a better deal but not without risk.

The good news is we will know in a few more months.
ENTA
rooster rooster 16 minutes ago
Crazy awesome… https://x.com/steve1055k/status/1915975586863853878?s=46&t=qLQnO1TjeygtFbhEqQdlmg
BDEZ BDEZ 17 minutes ago
NFL now has a trans cheerleader..................i don't watch sports of any kind but this not shocking at all.

https://x.com/janninereid1/status/1916270733006934079
rooster rooster 18 minutes ago
It seems like that might excite you thinking about that
AlwaysOptimistic AlwaysOptimistic 18 minutes ago
Greenmets CEO, Drew Horn, I’m guessing was the catalyst to getting face time with DJT following the Fox interview.
DJT
XMaster2023 XMaster2023 19 minutes ago
It’s all about the next step.

The Combination Therapy.

Of course you know this.
NWBO
axelvento axelvento 28 minutes ago
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

https://www.pfizer.com/news/press-release/press-release-detail/pfizers-sasanlimab-combination-significantly-improves-event?cid=tw_pbg_onco_aua-2025_042
BCG
B402 B402 31 minutes ago
If you don't allow systemic change you wont be saving, you will finish it off

Im betting on the latter....
life143 life143 33 minutes ago
Lol, sleepy Joe wasn't much better.
XRPUSD
life143 life143 35 minutes ago
We buy crypto here in Canada, we just have regulations on certain exchanges we are not allowed to use that don't comply with ontario law.
XRPUSD
BDEZ BDEZ 36 minutes ago
They have no choice but to push back. Been going on for thousands of years...
fnyack fnyack 36 minutes ago
You missed it because spring have passed, or maybe it bever sprung for Shiba.
SHIBUSD
nwtf nwtf 37 minutes ago
LOL still delusional after all these years.
ERHE
GreenShoots GreenShoots 37 minutes ago
That would make it about $9 a share as it was trading at about $48 per share then. Gov't owns 80%
FNMA
MasterBlastr MasterBlastr 37 minutes ago
You know what the Dems are going to do to save the country. Same as the Independents. Vote the bums out in '26.
fnyack fnyack 38 minutes ago
Is Shib about to add another big fat Zero?
SHIBUSD
Guido2 Guido2 39 minutes ago
In 2006 Fannie earned $3.50 per share. In 2024 Fannie earned $14.65 per share or roughly 4 times more than in 2006. Shouldn't the stock price be 4 times as much? If you agree, it's easily over $200. Now consider all the shorting going on. What do you think will happen?

Freddie earns e
FNMA

Your Recent History

Delayed Upgrade Clock